Our research revealed that WTAP could promote osteogenic differentiation and inhibit adipogenic differentiation of BMSCs through the YTHDC1/ miR-181a and miR-181c /SFRP1 axes, which could be of significance in developing therapeutic targets for osteoporosis. Here, SFRP1 is linked to osteoporosis.